Head and neck cancer during pregnancy.
birth control
carcinogenesis
head and neck cancer
hormone
immunology
molecular biology
pregnancy
treatment
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
14
03
2019
revised:
28
06
2019
accepted:
03
07
2019
pubmed:
23
7
2019
medline:
12
9
2020
entrez:
23
7
2019
Statut:
ppublish
Résumé
The incidence of cancer during pregnancy is low but is slightly increasing. Data on incidence and etiology of head and neck (HN) cancers in pregnant women are rare. We evaluated the frequency, tumor type, associated factors, and specific biomarkers in HN cancers occurring in pregnant (and peripartum) women. A systematic literature search was performed on PubMed, for any HN tumor site occurring in pregnant women. Sixty cases of HN cancers occurring during pregnancy were identified. Most of them were oral cavity cancers. Relationships with oncogenic viruses, hormonal disturbance, and shift in maternal immunity profile were identified. Carcinogenesis of HN cancers in pregnant women may be led by different cancer type-specific hallmarks. Relevance of these etiological factors with respect to treatments and birth control recommendations is being investigated by the REFCOR in an ambispective study.
Sections du résumé
BACKGROUND
The incidence of cancer during pregnancy is low but is slightly increasing. Data on incidence and etiology of head and neck (HN) cancers in pregnant women are rare. We evaluated the frequency, tumor type, associated factors, and specific biomarkers in HN cancers occurring in pregnant (and peripartum) women.
METHODS
A systematic literature search was performed on PubMed, for any HN tumor site occurring in pregnant women.
RESULTS
Sixty cases of HN cancers occurring during pregnancy were identified. Most of them were oral cavity cancers. Relationships with oncogenic viruses, hormonal disturbance, and shift in maternal immunity profile were identified.
CONCLUSION
Carcinogenesis of HN cancers in pregnant women may be led by different cancer type-specific hallmarks. Relevance of these etiological factors with respect to treatments and birth control recommendations is being investigated by the REFCOR in an ambispective study.
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3719-3732Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42(2):126-140.
Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy: a review of the literature. Part I. Obstet Gynecol Surv. 1996;51:125-134.
Layton SA. Oral carcinoma in pregnancy. Br J Oral Maxillofac Surg. 1992;30:161-164.
Cheung EJ. Advanced oral tongue cancer in a 22-year-old pregnant woman. Ann Otol Rhinol Laryngol. 2009;118:21-26.
Chow VL. Management of head and neck tumours during pregnancy: case report and literature review. Asian J Surg. 2008;31:199-203.
Succo G. Oropharyngeal carcinoma during pregnancy: clinical and psycho-oncological aspects. Acta Otorhinolaryngol Ital. 2003;23:440-445.
Morrison AE, Lang PG. Case of rapidly enlarging dermatofibrosarcoma protuberans during pregnancy followed by metastasis in the absence of local recurrence. Dermatol Surg. 2006;32(1):125-127.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-674. https://doi.org/10.1016/j.cell.2011.02.013.
Eliassen AM, Hauff SJ, Tang AL, et al. Head and neck squamous cell carcinoma in pregnant women. Head Neck. 2013;35(3):335-342.
Unsworth JD, Baldwin A, Byrd L. Systemic lupus erythematosus, pregnancy and carcinoma of the tongue. BMJ Case Rep. 2013;2013:bcr2013008864. https://doi.org/10.1136/bcr-2013-008864.
Yokoshima K, Nakamizo M, Sakanushi A, et al. Surgical management of tongue cancer during pregnancy. Auris Nasus Larynx. 2012;39(4):428-430. https://doi.org/10.1016/j.anl.2011.08.003.
Mhallem Gziri M, Han SN, Van Calsteren K, et al. Tongue cancers during pregnancy: case reports and review of literature. Head Neck. 2013;35(4):E102-E108. https://doi.org/10.1002/hed.21924.
Cheung EJ, Wagner H Jr, Botti JJ, Fedok F, Goldenberg D. 2009. Advanced oral tongue cancer in a 22-year-old pregnant woman. Ann Otol Rhinol Laryngol. 2009;118(1):21-26.
Atabo A, Patrick JB. Management principles of head and neck cancer during pregnancy: a review and case series. Oral Oncol. 2008;44(3):236-241.
Dumper J, Kerr P. Recurrent squamous cell carcinoma of the tongue in pregnancy. J Otolaryngol. 2005;34(4):242-243.
T. Koike S. Uehara H. Kobayashi K. Kurashina T. Yamazaki Case Report: Squamous cell carcinoma of the tongue during pregnancy experiences in two-year treatments Oral Oncology 41 1, 2005, 7-11. doi: https://doi.org/10.1016/j.ooe.2004.09.002
Lloyd CJ, Paley MD, Penfold CN, Varadarajan V, Tehan B, Gollins SW. Micro vascular free tissue transfer in the management of squamous cell carcinoma of the tongue during pregnancy. Br J Oral Maxillofac Surg. 2003;41(2):109-111. https://doi.org/10.1016/S0266-4356(03)00003-2.
Prado KL, Nelson SJ, Nuyttens JJ, Williams TE, Vanek KN. Clinical implementation of the AAPM task group: 36 recommendations on fetal dose from radiotherapy with photon beams: a head and neck irradiation case report. J Appl Clin Med Phys. 2000;1(1):1-7.
Lasaridis N, Tilaveridis I, Karakasis D. Management of a carcinoma of the tongue during pregnancy: report of case. J Oral Maxillofac Surg. 1996;54(2):221-224.
Terada T, Uwa N, Sagawa K, et al. A case of tongue carcinoma resection and reconstruction with microsurgical free flap during pregnancy. Nihon Jibiinkoka Gakkai Kaiho. 2015;118(1):46-52.
Shibuya H, Saiot M, Horiuchi JI, Suzuki S. Treatment of malignant headand neck tumors during pregnancy-a report of 3 cases. Acta Oncol. 1987;26(3):237-238.
Tagliabue M, Elrefaey SH, Peccatori F, et al. Tongue cancer during pregnancy: surgery and more, a multidisciplinary challenge. Crit Rev Oncol Hematol. 2016;98:1-11. https://doi.org/10.1016/j.critrevonc.2015.09.006.
Kansu L, Aydin E. Hypopharyngeal cancer in a pregnant woman. Am J Otolaryngol. 2012;33(1):174-177. https://doi.org/10.1016/j.amjoto.2011.02.007.
Liu Y, Liu Y, Wang Y, Chen X, Chen H, Zhang J. Malignancies associated with pregnancy: an analysis of 21 clinical cases. Ir J Med Sci. 2015;184:175-181. https://doi.org/10.1007/s11845-014-1083-6.
Lin TI1, Lin JC, Ho ES, Chou MM. Nasopharyngeal carcinoma during pregnancy. Taiwan J Obstet Gynecol 2007;46(4):423-6.
Pytel J, Gerlinger I, Arany A. Twin pregnancy following in vitro fertilisation coinciding with laryngeal cancer. ORL J Otorhinolaryngol Relat Spec. 1995;57(4):232-234.
Matschke RG, Gräber T, Panagiotopoulos A. A laryngeal cancer in pregnancy. [article in German]. HNO. 1994;42(8):505-508.
Panagiotopoulos A, Matschke R, Faber P. Pregnancy and laryngeal cancer [article in German]. Geburtshilfe Frauenheilkd. 1993;53(1):64-65.
Ferlito A, Nicolai P. Laryngeal cancer in pregnancy. Acta Otorhinolaryngol Belg 1980;34(6):706-9.
Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg. 2002;128(3):268-274.
Mallet Y, Avalos N, Le Ridant AM, et al. Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less. Acta Otolaryngol. 2009;129(12):1503-1508.
O'Regan EM, Toner ME, Smyth PC, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients. Head Neck. 2006;28:3308.
Jie-Hua Y, Caisen L, Yuhua H. Pregnancy and nasopharyngeal carcinoma: a prognostic evaluation of 27 patients. Int J Radiat Ther. 1984;10(6):851-855.
Cheng YK, Zhang F, Tang LL, et al. Pregnancy associated nasopharyngeal carcinoma: a retrospective case-control analysis of maternal survival outcomes. Radiother Oncol. 2015;116(1):125-130.
Zhang et al. Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysis. Oncotarget. 2016;7(16):21913-21921. https://doi.org/10.18632/oncotarget.8008.
Feldman BA. Rhabdomyosarcoma of the head and neck. Laryngoscope. 1982;92(4):424-440.
Tapisiz OL, Gungor T, Ustunyurt E, Ozdal B, Bilge U, Mollamahmutoglu L. An unusual case of lingual alveolar soft part sarcoma during pregnancy. Taiwan J Obstet Gynecol. 2008;47(2):212-214.
Williams AO, Martinson FD, Alli AF. Rhabdomyosarcoma of the upper respiratory tract in Ibadan, Nigeria. Br J Cancer. 1968;22(1):12-18.
Ortiz M, Giraldez LA, Riera-March A. Synovial sarcoma of the hypopharynx in pregnancy. Bol Asoc Med P R. 2012;104(3):55-56.
Karapantzos I, Behrman R, Kehl R, Markmann H-U. Angiosarkom des nasenseptums. Laryngo-Rhino-Otol. 1998;77:513-516.
Cotter CJ, Renny N. Comment on polymorphous low-grade adenocarcinoma-a rare and aggressive entity in adolescence. Br J Oral Maxillofac Surg. 2004;42(3):195-199.
Prabhu RV, Dinkar A, Spadigam A, Prabhu V. Low-grade papillary adenocarcinoma of minor salivary glands in pregnancy. Indian J Cancer. 2015;52(4):644-645. https://doi.org/10.4103/0019-509X.178438.
Takita M. Adenoid cystic carcinoma of the palate in pregnancy: report of a case. Osaka Daigaku Shigaku Zasshi. 1989;34(1):255-263.
Hoorn EJ. Olfactory neuroblastoma with hyponatremia. J Clin Oncol. 2015;33(21):e88.#x2010;e92. https://doi.org/10.1200/JCO.2013.49.1464.
Skorek A, Stankiewicz C, Preis K, Kiciński K, Iżycka-Świeszewska E. Malignant tumor of nasal cavity during pregnancy. Case report. Otolaryngol pol. 2012;66(6):428-431. https://doi.org/10.1016/j.otpol.2012.10.001.
Senchak A, Freeman J, Ruhl D, et al. Low-grade esthesioneuroblastoma presenting as SIADH: a review of atypical manifestations. Case Rep Otolaryngol. 2012;2012:582180.
Dascalu S, Chayen B, Kaplan B, Harel L. Olfactory neuroblastoma as acute postpartum depression. J Am Board Fam Pract. 1998;11(5):414-416.
Juan F, López JC, Arrazubi V, et al. An unusual neck tumor in a young pregnant woman: challenge diagnosis and response to treatment. Oxf Med Case Reports. 2017;2017(8):omx039.
Gherman RB, Bowen E, Eggleston MK, Karakla D. Desmoid tumor of the larynx complicating pregnancy: a case report. Am J Obstet Gynecol. 1999;180(4):1036-1037.
Mikaelian DO, Contrucci RB, Batsakis JG. Epithelial-myoepithelial carcinoma of the subglottic region: a case presentation and review of the literature. Otolaryngol Head Neck Surg. 1986;95(1):104-106.
Werner JA, Hansmann ML, Lippert BM, Rudert H. Laryngeal paraganglioma and pregnancy. ORL J Otorhinolaryngol Relat Spec. 1992;54(3):163-167.
Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997;17(4A):2683-2706.
Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3):276-280.
Platek ME, Merzianu M, Mashtare TL, et al. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. 2011;6:41.
Fiore M, Coppola S, Cannell AJ, et al. Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg. 2014;259(5):973e8.
Reitamo JJ, Scheinin TM, Hayry P. The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg. 1986;151(2):230e7.
Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283-291.
Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999;17(3):855-861.
Zemlickis D, Lishner M, Koren G. Review of foetal effects of cancer chemotherapeutic agents.
Koren G, Lishner M, Farine D, eds. Cancer and Pregnancy, Maternal and Foetal Risks. Cambridge: Cambridge University Press; 1996:168-180.
Lishner M. Cancer in pregnancy. Ann Oncol. 2003;14(Suppl. 3):31-36.
Zagouri F, Sergentanis TN, Chrysikos D, Bartsch R. Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis. Obstet Gynecol. 2013;121(2 (Pt 1)):337-343.
Sood AK, Shahin MS, Sorosky JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol. 2001;83(3):599-600.
Janne PA, Rodriguez-Thompson D, Metcalf DR, et al. Chemotherapy for a patient with advanced non small cell lung cancer during pregnancy: a case report and review of chemotherapy treatment during pregnancy. Oncology. 2001;61(3):175-183.
Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother. 2002;6:352-357.
He J, Shen N, Huang X. Thyroid carcinoma cells produce PLGF to enhance metastasis. Tumour Biol. 2015;36(11):8601-8607. https://doi.org/10.1007/s13277-015-3548-2.
Bu J, Bu X, Liu B, Chen F, Chen P. Inhibition of metastasis of oral squamous cell carcinoma by anti-PLGF treatment. Tumor Biol. 2015;36:2695-2701.
Rebmann V, Switala M, Eue I, Schwahn E, Merzenich M, Grosse-Wilde H. Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos. Hum Immunol. 2007;68:251-258.
Ferreira L, Torsten B, Meissner TT, Strominger JL. HLA-G: at the interface of maternal-fetal tolerance trends in immunology. Trends Immunol. 2017;38(4):272-286. https://doi.org/10.1016/j.it.2017.01.009.
Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-a immunotherapy. Cancer. 2001;92:369-376.
Russell S, Angell T, Lechner M, et al. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol. 2013;5(3):24.
Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA. 1997;94(10):5249-5254.
D'Addio F, Riella LV, Mfarrej BG, et al. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol. 2011;187(9):4530-4541. https://doi.org/10.4049/jimmunol.1002031.
Feldman R, Gatalica Z, Knezetic J, et al. Molecular profiling of head and neck squamous cell carcinoma. Head Neck. 2016;38(Suppl 1):E1625-E1638. https://doi.org/10.1002/hed.24290.
Hanna GJ, Woo SB, Li YY, Barletta JA, Hammerman PS, Lorch JH. Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018;47(5):568-577. https://doi.org/10.1016/j.ijom.2017.09.006
Azim HA Jr, Brohée S, Peccatori FA, et al. Biology of breast cancer during pregnancy using genomic profiling. Endocr Relat Cancer. 2014;21(4):545-554. https://doi.org/10.1530/ERC-14-0111.
Senapati R, Senapati NN, Dwibedi B. Molecular mechanisms of HPV mediated neoplastic progression infect agent cancer. 2016;11:59 eCollection 2016.
Herber R, Liem A, Pitot H, Lambert PF. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol. 1996;70:1873-1881.
Chung SH, Shin MK, Korach KS, Lambert PF. Requirement for stromal estrogen receptor alpha in cervical neoplasia. Hormones Cancer. 2013;4:50-59.
Nilsson S, Mäkelä S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev. 2001;81:1535-1565.
Gómez-Gómez Y, Organista-Nava J, Ocadiz-Delgado R, et al. The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17β-estradiol. Int J Oncol. 2016;49(2):549-558. https://doi.org/10.3892/ijo.2016.3575.
Naderali E, Khaki AA, Rad JS, Ali-Hemmati A, Rahmati M, Charoudeh HN. Regulation and modulation of PTEN activity. Mol Biol Rep. 2018;45:2869-2881. https://doi.org/10.1007/s11033-018-4321-6.
Molteni A, Warpeha RL, Brizio-Molteni L, Fors EM. Estradiol receptor-binding protein in head and neck neoplastic and normal tissue. Arch Surg. 1981;116(2):207-210.
Park JS, Rhyu JW, Kim CJ, et al. Neoplastic change of squamo-columnar junction in uterine cervix and vaginal epithelium by exogenous estrogen in hpv-18 URR E6/E7 transgenic mice. Gynecol Oncol. 2003;89(3):360-368.
Morris MA, Laverick L, Wei W, et al. The EBV-encoded oncoprotein, LMP1, induces an epithelial-to-mesenchymal transition (EMT) via its CTAR1 domain through integrin-mediated ERK-MAPK signalling. Cancer. 2018;10(5):E130. https://doi.org/10.3390/cancers10050130.
Wakisaka N, Kondo S, Yoshizaki T, Murono S, Furukawa M, Pagano JS. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol. 2004;24:5223-5234.
Christian ML, Iams J, Porter K, Glaser R. Epstein-Barr virus reactivation during pregnancy and postpartum: effects of race and racial discrimination. Brain Behav Immun. 2012;26(8):1280-1287.
Fortner RT, Schock H, Kaaks R, et al. Early pregnancy sex steroids and maternal breast cancer: a nested case-control study. Cancer Res. 2014;74:6958-6967.
Lukanova A, Surcel HM, Lundin E, et al. Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer. 2012;130:910-920.
Lukits J, Remenár E, Rásó E, Ladányi A, Kásler M, Tímár J. Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer. Int J Oncol. 2007;30:155-160.
Sumida T, Ishikawa A, Mori Y. Stimulation of the estrogen axis induces epithelial-mesenchymal transition in human salivary cancer cells. Cancer Genomics Proteomics. 2016;13(4):305-310.
Murase R, Sumida T, Ishikawa A, et al. Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer. Int J Otolaryngol. 2011;2011:1-9. https://doi.org/10.1155/2011/187623.
Fei M, Zhang J, Zhou J, Xu Y, Wang J. Sex-related hormone receptor in laryngeal squamous cell carcinoma: correlation with androgen estrogen-ɑ and prolactin receptor expression and influence of prognosis. Acta Otolaryngol. 2018;138(1):66-72. https://doi.org/10.1080/00016489.2017.1373851.
Schwartz N, Chaudhri RA, Hadadi A, Schwartz Z, Boyan BD. 17Beta-estradiol promotes aggressive laryngeal cancer through membrane-associated estrogen receptor-alpha 36. Horm Cancer. 2014;5(1):22-32. https://doi.org/10.1007/s12672-013-0161-y.
Hamakawa H, Nakashiro K, Sumida T, et al. Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer. Head Neck. 2008;30(6):800-809.
Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003;119(6):801-806.